Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IFN-A, TIL, and IL-2 in Metastatic Cancer
NCT00002733Phase 2Completed
- Sponsor
- Hoag Memorial Hospital Presbyterian
- Start
- Jan 1996
- Primary completion
- Jan 2000
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of therapeutic tumor-infiltrating lymphocytes in metastatic cancer, melanoma, renal cell carcinoma (RCC), sponsored by Hoag Memorial Hospital Presbyterian. Started Jan 1996; status: completed.
02
Drugs
therapeutic tumor-infiltrating lymphocytes
03
Conditions
metastatic cancermelanomarenal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00002733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002733.